Nutri Pharmaceuticals Research Inc
Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its "oil to powder' products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and org… Read more
Nutri Pharmaceuticals Research Inc (NRPR) - Total Liabilities
Latest total liabilities as of December 2003: $437.63K USD
Based on the latest financial reports, Nutri Pharmaceuticals Research Inc (NRPR) has total liabilities worth $437.63K USD as of December 2003.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nutri Pharmaceuticals Research Inc - Total Liabilities Trend (2003–2003)
This chart illustrates how Nutri Pharmaceuticals Research Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nutri Pharmaceuticals Research Inc Competitors by Total Liabilities
The table below lists competitors of Nutri Pharmaceuticals Research Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sinar Terang Mandiri PT Tbk
JK:MINE
|
Indonesia | Rp1.27 Trillion |
|
Minoan Group
LSE:MIN
|
UK | GBX9.59 Million |
|
CHAODA MODERN AGRI
BE:CHA
|
Germany | €34.61 Million |
|
CHINA OIL AND GAS - Dusseldorf Stock Exchang
DU:GPI1
|
Germany | €13.28 Billion |
|
Lauritz.com A/S
ST:LAUR
|
Sweden | Skr185.67 Million |
Liability Composition Analysis (2003–2003)
This chart breaks down Nutri Pharmaceuticals Research Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nutri Pharmaceuticals Research Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nutri Pharmaceuticals Research Inc (2003–2003)
The table below shows the annual total liabilities of Nutri Pharmaceuticals Research Inc from 2003 to 2003.
| Year | Total Liabilities | Change |
|---|---|---|
| 2003-12-31 | $437.63K | -- |